949916-64-7

Usage

Uses

Used in Pharmaceutical Research:
(S)-1-CBZ-AMINO-BUTYL-3-AMINE is utilized as a key intermediate in the production of pharmaceutical compounds. Its unique structure and functional groups, including the CBZ and amine groups, make it a versatile building block for creating a wide range of molecules with diverse functionalities and applications in the development of new drugs.
Used in Organic Synthesis:
In the field of organic synthesis, (S)-1-CBZ-AMINO-BUTYL-3-AMINE serves as a valuable building block. Its presence allows for the creation of various types of molecules, contributing to the synthesis of complex organic compounds for a multitude of applications, such as in materials science, chemical research, and the production of specialty chemicals.
Used in Agrochemical Production:
(S)-1-CBZ-AMINO-BUTYL-3-AMINE also finds application in the agrochemical industry. It is used as an intermediate in the synthesis of compounds that can be employed in the development of pesticides, herbicides, and other agricultural chemicals, thereby contributing to the enhancement of crop protection and yield.

Upstream product

• 501-53-1 benzyl chloroformate 
• 949916-62-5 (3S)-N¹-(benzyloxycarbonyl)-N³-(tert-butyloxycarbonyl)-1,3-diaminobutane 

Relevant academic research and scientific papers

Synthesis of (3R,10R)- and (3S,10S)-Diastereomers of 3,10-Dimethylspermine

Abstract: A simple and practical 10-step synthesis is reported for previously unknown diastereomers of C?methylated spermine (Spm) analogue, 1,12-diamino-3,10-dimethyl-4,9-diazadodecane (3,10-Me2Spm), starting from commercially available enanti

Enantioselective synthesis of (R)- and (S)-3-methylspermidines

Earlier unknown enantiomerically pure (R)- and (S)-1,8-diamino-3-methyl-4-azaoctane's (3-MeSpd's) were synthesized within 11 steps with high overall yields and optical purity starting from commercially available R- and S-isomers of N-Boc-2-aminopropanol-1

SUBSTITUTED FUSED[1,2]IMIDAZO[4,5-C] RING COMPOUNDS AND METHODS

[1,2]Imidazo[4,5-c] ring compounds (e.g., imidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, and imidazo[4,5-c]pyridines) substituted with a fused ring containing an oxygen and/or nitrogen atom attached at the 1- and/or 2-position, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.